MagVenture Announces FDA Clearance for MeRT System for PTSD
MagVenture has announced that Wave Neuroscience’s MeRT® system has received FDA clearance for the treatment of PTSD, utilizing MagVenture® technology. This system is part of the TMS therapy being administered to patients diagnosed with PTSD.
ALPHARETTA, GA, UNITED STATES, June 18, 2026 /EINPresswire.com/ — MagVenture®, a global leader of non-invasive TMS neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Wave Neuroscience’s …